V025-2553 Screening compound: 3-chloro-N-({1-cyclohexyl-2-[(3-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-ethylbenzamide

V025-2553 Screening compound: 3-chloro-N-({1-cyclohexyl-2-[(3-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-ethylbenzamide
V025-2553 Screening compound: 3-chloro-N-({1-cyclohexyl-2-[(3-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-ethylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-2553
3-chloro-N-({1-cyclohexyl-2-[(3-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-ethylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-2553

Molecular Formula

C27H32ClN3O3S (C27 H32 ClN3 O3 S)

Compound Name

3-chloro-N-({1-cyclohexyl-2-[(3-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-ethylbenzamide

IUPAC name

3-chloro-N-({1-cyclohexyl-2-[(3-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-ethylbenzamide

SMILES

CCN(Cc(n1C2CCCCC2)cnc1S(Cc1cc(C)ccc1)(=O)=O)C(c1cccc(Cl)c1)=O

InChI

InChI=1S/C27H32ClN3O3S/c1-3-30(26(32)22-11-8-12-23(28)16-22)18-25-17-29-27(31(25)24-13-5-4-6-14-24)35(33,34)19-21-10-7-9-20(2)15-21/h7-12,15-17,24H,3-6,13-14,18-19H2,1-2H3

InChI Key

MWJQLWMMVSTMRZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19815782

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

514.09

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.651

Distribution Coefficient, logD

5.651

Water Solubility, LogSw

-5.76

Polar Surface Area

57.164

Acid Dissociation Constant (pKa)

20.02

Base Dissociation Constant (pKb)

-1.41

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.70

V025-2553 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Regenerative Medicine Focused Library (23016 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with V025-2553 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-2553?
Check Price and Availability of V025-2553, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-2553 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-2553
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-2553
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-2553 available by request